Last month was my final trial month of the new med trial using a low dose of the anti-depressant nortriptyline as a daily preventative, with the abortive naratriptan to be taken as needed for severe migraine attacks. My results were…mixed. I had two weeks of no migraines at all – a new record since the spike in attacks back in 2018. The average number of attacks had lowered from three to two a week. However, the migraines I was getting were far more severe, enough so that I finally went to urgent care.
I would regret stepping foot in that office by the time I was through.
Continue reading